Women on testoterone therapy have improved memory: Study

Image
Press Trust of India Melbourne
Last Updated : Jun 24 2013 | 12:55 PM IST
Women on testosterone therapy, after menopause showed a significant improvement in verbal learning and memory, a study by Australian researchers has said.
The research led by Susan Davis, Director of the Women's Health Research Program at Monash University is the first large radomised, placebo-controlled investigation into the effects of testosterone on cognitive function in postmenopausal women which offer a promising avenue for research into memory and ageing, said a statement by the University.
Testosterone has been implicated as being important for brain function in men and these results indicate that it has a role in optimising learning and memory in women.
Dementia which was estimated to affect more than 35 million people worldwide in 2010, is more common in women than men. There are no effective treatments to prevent memory decline.
In the study, 96 postmenopausal women recruited from the community were randomly allocated to receive a testosterone gel or a visually identical placebo gel to be applied to the skin.
Participants underwent a comprehensive series of cognitive tests at the beginning of the study and 26 weeks later.
All women performed in the normal range for their age at the beginning of the trial.
There was a statistically significant and clinically meaningful improvement in verbal learning and memory amongst the women using the testosterone gel after 26 weeks.
Davis said the results indicated that testosterone played an important role in women's health.
"Much of the research on testosterone in women to date has focused on sexual function. But testosterone has widespread effects in women, including, it appears, significant favourable effects on verbal learning and memory," Davis said
"Our findings provide compelling evidence for the conduct of larger clinical studies to further investigate the role of testosterone in cognitive function in women," she said.
Androgen levels did increase in the cohort on testosterone therapy, but on average, remained in the normal female range.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 24 2013 | 12:55 PM IST

Next Story